At multivariate analysis adjusted for CRP levels, the number of 736 V TMPRSS6 alleles carried by CHD patients was associated with the weight-adjusted Epo dosage required to achieve the target Hb levels (p = 0.02, estimate coefficient 45, 95% c.i. 7-82). Here, GSTM1 is linked to coronary artery disorder.